These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6341016)

  • 1. Absorption and miscibility of regular porcine insulin after subcutaneous injection of insulin-treated diabetic patients.
    Kølendorf K; Bojsen J; Deckert T
    Diabetes Care; 1983; 6(1):6-9. PubMed ID: 6341016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical factors influencing the absorption of 125I-NPH insulin in diabetic patients.
    Kølendorf K; Bojsen J; Deckert T
    Horm Metab Res; 1983 Jun; 15(6):274-8. PubMed ID: 6409773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption, effectiveness and side effects of highly purified porcine NPH-insulin preparations (Leo).
    Kølendorf K; Aaby P; Westergaard S; Deckert T
    Eur J Clin Pharmacol; 1978 Nov; 14(2):117-24. PubMed ID: 363432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in absorption of NPH insulin due to intramuscular injection.
    Vaag A; Handberg A; Lauritzen M; Henriksen JE; Pedersen KD; Beck-Nielsen H
    Diabetes Care; 1990 Jan; 13(1):74-6. PubMed ID: 2404719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent subcutaneous absorption of porcine, bovine and human NPH insulins.
    Hildebrandt P; Birch K; Sestoft L; Vølund A
    Acta Med Scand; 1984; 215(1):69-73. PubMed ID: 6364700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the subcutaneous absorption of insulin glargine (Lantus) and NPH insulin in patients with Type 2 diabetes.
    Luzio SD; Beck P; Owens DR
    Horm Metab Res; 2003 Jul; 35(7):434-8. PubMed ID: 12931275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous use of regular human insulin (Novo): pharmacokinetics and continuous insulin infusion therapy.
    Sonnenberg GE; Kemmer FW; Cüppers HJ; Berger M
    Diabetes Care; 1983; 6 Suppl 1():35-9. PubMed ID: 6343035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of insulin after continuous subcutaneous infusion or bolus subcutaneous injection in diabetic patients.
    Kobayashi T; Sawano S; Itoh T; Kosaka K; Hirayama H; Kasuya Y
    Diabetes; 1983 Apr; 32(4):331-6. PubMed ID: 6339306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption of isophane (NPH) insulin and its clinical implications.
    Lauritzen T; Pramming S; Gale EA; Deckert T; Binder C
    Br Med J (Clin Res Ed); 1982 Jul; 285(6336):159-62. PubMed ID: 6807390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotelemetric detection of the disappearance of subcutaneously injected 125I-NPH insulin.
    Kølendorf K; Bojsen J
    Clin Physiol; 1982 Feb; 2(1):13-20. PubMed ID: 7049511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sauna-induced acceleration in insulin absorption from subcutaneous injection site.
    Koivisto VA
    Br Med J; 1980 Jun; 280(6229):1411-3. PubMed ID: 7000239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of leg exercise on insulin absorption in diabetic patients.
    Koivisto VA; Felig P
    N Engl J Med; 1978 Jan; 298(2):79-83. PubMed ID: 619237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption kinetics and biologic effects of subcutaneously injected insulin preparations.
    Berger M; Cüppers HJ; Hegner H; Jörgens V; Berchtold P
    Diabetes Care; 1982; 5(2):77-91. PubMed ID: 6765510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption of NPH-insulin from subcutaneous tissue: a methodological study in pigs.
    Deckert T; Hansen B; Kølendorf K; Poulsen JS; Smith M
    Acta Pharmacol Toxicol (Copenh); 1982 Jul; 51(1):30-7. PubMed ID: 6751023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of a 40 IU/ml porcine lente insulin preparation in diabetic cats: findings during the first week and after 5 or 9 weeks of therapy.
    Martin GJ; Rand JS
    J Feline Med Surg; 2001 Mar; 3(1):23-30. PubMed ID: 11716627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous absorption of U-40 and U-100 insulin.
    Lauritzen T; Thorsteinsson B; Pramming S; Sørensen L; Binder C
    Horm Metab Res; 1984 Nov; 16(11):611-2. PubMed ID: 6392055
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of the anatomical region used for insulin injections on glycemia in type I diabetes subjects.
    Bantle JP; Neal L; Frankamp LM
    Diabetes Care; 1993 Dec; 16(12):1592-7. PubMed ID: 8299455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin antibodies do not influence the absorption rate of subcutaneously injected insulin.
    de Meijer PH; Lutterman JA; van't Laar A
    Diabet Med; 1988 Nov; 5(8):776-81. PubMed ID: 2975571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rise in ambient temperature augments insulin absorption in diabetic patients.
    Koivisto VA; Fortney S; Hendler R; Felig P
    Metabolism; 1981 Apr; 30(4):402-5. PubMed ID: 7010077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The absorption of subcutaneously injected short-acting soluble insulin: influence of injection technique and concentration.
    Hildebrandt P; Sestoft L; Nielsen SL
    Diabetes Care; 1983; 6(5):459-62. PubMed ID: 6400706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.